Candel Therapeutics, Inc.
CADL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,269 | -$4,796 | $7,379 | -$14,073 |
| Dep. & Amort. | $195 | $242 | $245 | $245 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,163 | $1,050 | $314 | $1,244 |
| Change in WC | $356 | $67 | -$1,825 | $743 |
| Other Non-Cash | -$681 | -$5,454 | -$14,729 | $6,027 |
| Operating Cash Flow | -$10,236 | -$8,891 | -$8,616 | -$5,814 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$144 | -$31 | -$3 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $27 | $0 | $0 | $0 |
| Investing Cash Flow | -$117 | -$31 | -$3 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,500 | -$2,500 | -$2,500 | -$2,500 |
| Stock Issued | -$713 | $19,698 | $384 | $94,043 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$158 | $246 | $246 | $370 |
| Financing Cash Flow | -$3,371 | $17,444 | -$1,870 | $91,913 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13,724 | $8,522 | -$10,489 | $86,096 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $100,953 | $92,431 | $102,920 | $16,824 |
| End Cash | $87,229 | $100,953 | $92,431 | $102,920 |
| Free Cash Flow | -$10,380 | -$8,922 | -$8,619 | -$5,817 |